Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Korean Partner Positions Pluristem To Be Cell Therapy Leader
Seeking Alpha
Tuesday, July 2, 2013 - 1:40am
tags:
Korea, Pluristem, Advanced Cell Technology, Cha Bio&Diostech
An Interesting Bio Play in the Blood Disorder Niche
Motley Fool
Tuesday, July 2, 2013 - 1:39am
tags:
hereditary angiodema, Dyax, Shire, CSL, ViroPharma, Biovitrum, Halozyme, Cinryze
ImmunoCellullar Therapeutics' Immune Modifying Approach To Cancer Is Worth Watching
Seeking Alpha
Tuesday, July 2, 2013 - 1:36am
tags:
ImmunoCellular Therapeutics, cancer, Dendreon, ICT-107
1 Reason to Expect Big Things from Allergan
Motley Fool
Tuesday, July 2, 2013 - 1:33am
tags:
Allergan
Pfizer, Novartis may join Amgen in bidding for Onyx: sources
Yahoo/Reuters
Tuesday, July 2, 2013 - 1:32am
tags:
Pfizer, Novartis, Amgen, ONYX Pharmaceutical, M&A
Achillion Hepatitis C Drug Trial on Hold on Liver Concern
Bloomberg
Tuesday, July 2, 2013 - 1:25am
tags:
Achillion, hepatitis C, sovaprevir
Teva trial data back higher dosage Copaxone
Globes, Israel
Monday, July 1, 2013 - 1:56pm
tags:
Teva, Copaxone, MS, multiple sclerosis
King Pharmaceuticals to pay $2.2M civil penalty for plant violations
Med City News
Monday, July 1, 2013 - 1:54pm
tags:
Pfizer, King Pharmaceuticals, drug manufacturing, Clean Air Act
Why Ligand Pharmaceuticals Shares Popped
Motley Fool
Monday, July 1, 2013 - 1:52pm
tags:
Ligand, hot flashes, Brisdelle, Hisamitsu, Pfizer, bazedoxifene
Biotech IPOs boom in Q2, enjoying a long-awaited embrace from investors
Fierce Biotech
Monday, July 1, 2013 - 1:10pm
tags:
biotech, IPOs
Vivus announces initial availability of Qsymia through certified pharmacies
Yahoo/Fly on the Wall
Monday, July 1, 2013 - 1:07pm
tags:
Qsymia, obesity, Vivus
Breaking Down Dendreon's European Recommendation
Motley Fool
Monday, July 1, 2013 - 1:06pm
tags:
Provenge, Europe, Dendreon, prostate cancer
Arena's Second Week Sales - Not Bad, But Not Good Either
Seeking Alpha
Monday, July 1, 2013 - 12:55pm
tags:
Arena Pharmaceuticals, Eisai, obesity, Belviq
The Best- And Worst-Performing Biotech Stocks In The First Half Of 2013
Forbes
Monday, July 1, 2013 - 12:54pm
tags:
biotech
Novartis Drug Patch Gets OK for Severe Alzheimer's
Med Page Today
Monday, July 1, 2013 - 12:48pm
tags:
Novartis, Alzheimer's disease, rivastigmine
Will Big Changes At Apricus Biosciences Make It A Winning Stock?
Seeking Alpha
Monday, July 1, 2013 - 12:47pm
tags:
Apricus Biosciences, RayVa, MycoVa, Vitaros, Femprox
Here's What We Know About The Brewing Bidding War For Onyx Pharmaceuticals
Forbes
Monday, July 1, 2013 - 12:44pm
tags:
Amgen, M&A, ONYX Pharmaceuticals, Bayer, Pfizer
Merck KGaA’s Oschmann Sees U.S. as New Emerging Market
Bloomberg
Monday, July 1, 2013 - 12:41pm
tags:
Merck KGaA
Amgen vs. Big Pharma: It's Amgen for the Long Term
Motley Fool
Monday, July 1, 2013 - 12:40pm
tags:
Amgen, Big Pharma, Merck, Bristol-Myers Squibb
Insmed retreats after Arikace results
The Fly on the Wall
Monday, July 1, 2013 - 12:39pm
tags:
Insmed, Arikace, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.